Previous media releases

UBS's first-quarter 2016 results

Zurich/Basel Price Sensitive Information

  

UBS 1Q adjusted profit before tax CHF 1.4 billion

  • Net profit attributable to UBS Group AG shareholders CHF 707 million; diluted earnings per share CHF 0.18
  • Fully applied CET1 capital ratio 14.0%; Swiss SRB fully applied leverage ratio 5.4%
  • UBS raises record USD 471 million Oncology Impact Fund to develop cancer treatments

This website uses cookies to make sure you get the best experience on our website. You can find more information under the Privacy Statement. You are free to change your cookies' settings in the privacy settings.

Go to privacy settings